Cell lines and PDX models were routinely authenticated by SNP fingerprinting and tested for mycoplasma. HPB-ALL was obtained from Andreas Strasser. TALL-1, RPMI-8402, SUPT11, Loucy, P12-Ichikawa, PF382 were purchased from DSMZ. Jurkat (clone E6-1), U2OS, MDA-MB-468, HCC1143 were purchased from ATCC. HLR PathDetect cells were purchased from Stratagene. All other cell lines were obtained from the Novartis stocks of the Cancer cell line encyclopedia (27 (link)). T-ALL PDX models were created from primary T-ALLs by injection by tail vein into immunodeficient NOD/Scid/IL2rγnull (NSG) mice and are described at the online portal PRoXe at http://PRoXe.org. Detergent extracts of T-ALL cells obtained from the marrows of leukemia-bearing mice were analyzed for activated NOTCH1 (ICD1) and activated NOTCH3 (ICD3) by Western blotting.